 | Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial (PDF) - Sep 2023 (clinical)
|
 | Repeat polymorphisms underlie top genetic risk loci for glaucoma and colorectal cancer (PDF) - Sep 2023 (experimental)
|
 | Placebo effect and its determinants in ocular hypotensive therapy: meta-analysis and multiple meta-regression analysis (PDF) - Jul 2023 (clinical)
|
 | Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank (PDF) - Jul 2023 (experimental)
|
 | Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss (PDF) - Jun 2023 (clinical)
|
 | Ligand-induced activation and G protein coupling of prostaglandin F2α receptor (PDF) - Jun 2023 (experimental)
|
 | Validation of Rates of Mean Deviation Change as Clinically Relevant End Points for Glaucoma Progression (PDF) - May 2023 (clinical)
|
 | Longitudinal Changes of Bruch's Membrane Opening, Anterior Scleral Canal Opening, and Border Tissue in Experimental Juvenile High Myopia (PDF) - May 2023 (experimental)
|
 | MIND diet lowers risk of open-angle glaucoma: the Rotterdam Study (PDF) - Apr 2023 (clinical)
|
 | Prediagnostic Plasma Metabolomics and the Risk of Exfoliation Glaucoma (PDF) - Apr 2023 (experimental)
|
 | Evidence-Based Guidelines for the Number of Peripapillary OCT Scans Needed to Detect Glaucoma Worsening (PDF) - Mar 2023 (clinical)
|
 | Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant (PDF) - Mar 2023 (experimental)
|
 | Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline Results and Costs of a Cluster-Randomized Trial (PDF) - Feb 2023 (clinical)
|
 | Intracameral Injection of AAV-DJ.COMP-ANG1 Reduces the IOP of Mice by Reshaping the Trabecular Outflow Pathway (PDF) - Feb 2023 (experimental)
|
 | Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension (PDF) - Jan 2023 (clinical)
|
 | Cooperation of Angiopoietin-2 and Angiopoietin-4 in Schlemm's Canal Maintenance (PDF) - Jan 2023 (experimental)
|
 | Estimating the Length of the Preclinical Detectable Phase for Open-Angle Glaucoma (PDF) - Dec 2022 (clinical)
|
 | Thrombospondin 1 missense alleles induce extracellular matrix protein aggregation and TM dysfunction in congenital glaucoma (PDF) - Dec 2022 (experimental)
|
 | Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma (PDF) - Nov 2022 (clinical)
|
 | Relative Contributions of Intraocular and Cerebrospinal Fluid Pressures to the Biomechanics of the Lamina Cribrosa and Laminar Neural Tissues (PDF) - Nov 2022 (experimental)
|
 | Long-Term Alcohol Consumption and Risk of Exfoliation Glaucoma/Glaucoma Suspect among US Health Professionals (PDF) - Oct 2022 (clinical)
|
 | METTL23 mutation alters histone H3R17 methylation in normal-tension glaucoma (PDF) - Oct 2022 (experimental)
|
 | Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change (PDF) - Sep 2022 (clinical)
|
 | Single-cell transcriptome analysis of regenerating RGCs reveals potent glaucoma neural repair genes (PDF) - Sep 2022 (experimental)
|
 | Comparison of the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density: A Randomized Clinical Trial (PDF) - Jul 2022 (clinical)
|
 | Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells (PDF) - Jul 2022 (experimental)
|
 | Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (PDF) - Jun 2022 (clinical)
|
 | Intelligent wireless theranostic contact lens for electrical sensing and regulation of intraocular pressure (PDF) - Jun 2022 (experimental)
|
 | Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial (PDF) - May 2022 (clinical)
|
 | Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells' response to Pten deletion (PDF) - May 2022 (experimental)
|
 | Six-year incidence and risk factors for primary angle closure disease: The Singapore Epidemiology of Eye Diseases Study (PDF) - Apr 2022 (clinical)
|
 | Is Genetic Risk for Sleep Apnea Causally Linked With Glaucoma Susceptibility? (PDF) - Apr 2022 (experimental)
|
 | Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and Optical Coherence Tomography Imaging (PDF) - Mar 2022 (clinical)
|
 | Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma (PDF) - Mar 2022 (experimental)
|
 | The Weiss ring, a major confounding factor for measurements of peripapillary retinal nerve fiber layer thickness (PDF) - Feb 2022 (clinical)
|
 | GWAS identifies two common loci associated with pigment dispersion syndrome/pigmentary glaucoma and implicate myopia in its development (PDF) - Feb 2022 (experimental)
|
 | Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer (PDF) - Jan 2022 (clinical)
|
 | Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes (PDF) - Jan 2022 (experimental)
|
 | Attitudes towards polygenic risk testing in individuals with glaucoma (PDF) - Dec 2021 (clinical)
|
 | Cellular crosstalk regulates the aqueous humor outflow pathway and provides new targets for glaucoma therapies (PDF) - Dec 2021 (experimental)
|
 | Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma (PDF) - Nov 2021 (clinical)
|
 | GLIS1 regulates trabecular meshwork function and intraocular pressure and is associated with glaucoma in humans (PDF) - Nov 2021 (experimental)
|
 | In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty (PDF) - Oct 2021 (clinical)
|
 | Preservation of vision after CaMKII-mediated protection of retinal ganglion cells (PDF) - Oct 2021 (experimental)
|
 | Long-Term Outcomes of Selective Laser Trabeculoplasty for Open-Angle Glaucoma in the Caribbean (PDF) - Sep 2021 (clinical)
|
 | Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury (PDF) - Sep 2021 (experimental)
|
 | Gonioscopy-assisted transluminal trabeculotomy (GATT) for myocilin juvenile glaucoma (PDF) - Jul 2021 (clinical)
|
 | A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure (PDF) - Jul 2021 (experimental)
|
 | Ab-externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: 1-year Results from a 2-year Randomized, Multicenter Study (PDF) - Jun 2021 (clinical)
|
 | Impaired TRPV4-eNOS signaling in trabecular meshwork elevates intraocular pressure in glaucoma (PDF) - Jun 2021 (experimental)
|
 | Ten-Year Clinical Outcomes of Acute Primary Angle Closure Randomized to Receive Early Phacoemulsification Versus Laser Peripheral Iridotomy (PDF) - May 2021 (clinical)
|
 | Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries (PDF) - May 2021 (experimental)
|
 | Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial (PDF) - Apr 2021 (clinical)
|
 | Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye (PDF) - Apr 2021 (experimental)
|
 | Protrudin functions from the endoplasmic reticulum to support axon regeneration in the adult CNS (PDF) - Mar 2021 (experimental)
|
 | Anatomical Changes and Predictors of Angle Widening After Laser Peripheral Iridotomy: The Zhongshan Angle Closure Prevention Trial (PDF) - Feb 2021 (clinical)
|
 | Longitudinal Changes in Macular Optical Coherence Tomography Angiography Metrics in Primary Open-Angle Glaucoma With High Myopia: A Prospective Study (PDF) - Feb 2021 (experimental)
|
 | Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial (PDF) - Jan 2021 (clinical)
|
 | Peripapillary sclera exhibits a v-shaped configuration that is more pronounced in glaucoma eyes (PDF) - Jan 2021 (experimental)
|
 | Risk Factors for Visual Field Deterioration in the United Kingdom Glaucoma Treatment Study (PDF) - Dec 2020 (clinical)
|
 | Metabolomic profiling of aqueous humor from glaucoma patients - The metabolomics in surgical ophthalmological patients (MISO) study (PDF) - Dec 2020 (experimental)
|
 | Unplanned Return to the Operating Room After Trabeculectomy (PDF) - Nov 2020 (clinical)
|
 | Longitudinal Macular Ganglion Cell-Inner Plexiform Layer Measurements to Detect Glaucoma Progression in High Myopia (PDF) - Oct 2020 (clinical)
|
 | Lamina Cribrosa Capillaries Straighten as Intraocular Pressure Increases (PDF) - Oct 2020 (experimental)
|
 | Cardiovascular Disease may predict structural and functional progression in early glaucoma (PDF) - Sep 2020 (clinical)
|
 | Association of Glaucoma Risk Genes with Retinal Nerve Fiber Layer in a Multi-ethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study (PDF) - Sep 2020 (experimental)
|
 | Longitudinal Macular Structure–Function Relationships in Glaucoma (PDF) - Jul 2020 (clinical)
|
 | Efficacy for Differentiating Nonglaucomatous Versus Glaucomatous Optic Neuropathy Using Deep Learning Systems (PDF) - Jul 2020 (experimental)
|
 | Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (PDF) - Jun 2020 (clinical)
|
 | Using Deep Learning to Automate Goldmann Applanation Tonometry Readings (PDF) - Jun 2020 (experimental)
|
 | Franz Fankhauser: the father of the automated perimeter (PDF) - May 2020 (clinical)
|
 | Circadian Regulation of IOP Rhythm by Dual Pathways of Glucocorticoids and the Sympathetic Nervous System (PDF) - May 2020 (experimental)
|
 | The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study (PDF) - Mar 2020 (clinical)
|
 | Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry (PDF) - Mar 2020 (experimental)
|
 | Aniridia and Axenfeld-Rieger Syndrome: Clinical Presentations, Molecular Genetics and Current/Emerging Therapies (PDF) - Feb 2020 (clinical)
|
 | Electrophysiology in Glaucoma (PDF) - Feb 2020 (experimental)
|
 | Human versus Machine: Comparing a Deep Learning Algorithm to Human Gradings for Detecting Glaucoma on Fundus Photographs (PDF) - Dec 2019 (clinical)
|
 | Impairment of Membrane Repolarization Accompanies Axon Transport Deficits in Glaucoma (PDF) - Dec 2019 (experimental)
|
 | Glaucoma management in the era of artificial intelligence (PDF) - Nov 2019 (clinical)
|
 | Neuroprotection in Glaucoma: Towards Clinical Trials and Precision Medicine (PDF) - Nov 2019 (experimental)
|
 | Exogenous influences on intraocular pressure (PDF) - Oct 2019 (clinical)
|
 | Cholinergic nervous system and glaucoma: From basic science to clinical applications (PDF) - Oct 2019 (experimental)
|
 | Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion (PDF) - Sep 2019 (clinical)
|
 | microRNA dysregulation in neurodegenerative diseases: A systematic review (PDF) - Sep 2019 (experimental)
|
 | Effect of trabeculectomy on corneal endothelial cell loss (PDF) - Jul 2019 (clinical)
|
 | Potential role of P2X7 receptor in neurodegenerative processes in a murine model of glaucoma (PDF) - Jul 2019 (experimental)
|
 | Risk factors for disease progression in low-teens normal-tension glaucoma (PDF) - Jun 2019 (clinical)
|
 | Impact of Posterior Sclera on Glaucoma Progression in Treated Myopic Normal-Tension Glaucoma Using Reconstructed Optical Coherence Tomographic Images (PDF) - Jun 2019 (experimental)
|
 | Exogenous influences on intraocular pressure (PDF) - May 2019 (clinical)
|
 | Rapamycin Removes Damaged Mitochondria and Protects Human Trabecular Meshwork (TM-1) Cells from Chronic Oxidative Stress (PDF) - May 2019 (experimental)
|
 | Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial (PDF) - Apr 2019 (clinical)
|
 | Border Tissue Morphology is Spatially Associated with Focal Lamina Cribrosa Defect and Deep-Layer Microvasculature Dropout in Open-Angle Glaucoma (PDF) - Apr 2019 (experimental)
|
 | Visual Crowding in Glaucoma (PDF) - Mar 2019 (clinical)
|
 | Artificial intelligence and deep learning in ophthalmology (PDF) - Mar 2019 (experimental)
|
 | The Effects of Optic Nerve Head Tilt on Visual Field Defects in Myopic Normal Tension Glaucoma: The Inter-eye Comparison Study (PDF) - Feb 2019 (clinical)
|
 | Identification of Candidate miRNA Biomarkers for Glaucoma (PDF) - Feb 2019 (experimental)
|
 | Effects of Sex Hormones on Ocular Blood Flow and Intraocular Pressure in Primary Open-angle Glaucoma: A Review (PDF) - Jan 2019 (clinical)
|
 | Reduced Cerebrospinal Fluid Inflow to the Optic Nerve in Glaucoma (PDF) - Jan 2019 (experimental)
|
 | Artificial intelligence and deep learning in ophthalmology (PDF) - Dec 2018 (clinical)
|
 | Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review (PDF) - Dec 2018 (experimental)
|
 | Familial Risks of Glaucoma in the Population of Sweden (PDF) - Nov 2018 (clinical)
|
 | Mitochondrial DNA Variation and Disease Susceptibility in Primary Open-Angle Glaucoma (PDF) - Nov 2018 (experimental)
|
 | The Magnitude of IOP Elevation Associated with Eye Rubbing (PDF) - Oct 2018 (clinical)
|
 | Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma (PDF) - Oct 2018 (experimental)
|
 | Structural reversal of disc cupping after trabeculectomy alters Bruch's membrane opening-based parameters to assess neuroretinal rim (PDF) - Sep 2018 (clinical)
|
 | Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma (PDF) - Sep 2018 (experimental)
|
 | Tolerable rates of visual field progression in a population-based sample of patients with glaucoma (PDF) - Jul 2018 (clinical)
|
 | Nogo-A inactivation improves visual plasticity and recovery after retinal injury (PDF) - Jul 2018 (experimental)
|
 | Progression of Primary Open-Angle Glaucoma in Diabetic and Nondiabetic Patients (PDF) - Jun 2018 (clinical)
|
 | Glaucoma pathogenesis and neurotrophins: Focus on the Molecular and Genetic basis for Therapeutic prospects (PDF) - Jun 2018 (experimental)
|
 | What have we learned about exfoliation syndrome since its discovery by John Lindberg 100 years ago? (PDF) - May 2018 (clinical)
|
 | The coma in glaucoma: Retinal ganglion cell dysfunction and recovery (PDF) - May 2018 (experimental)
|
 | Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function (PDF) - Apr 2018 (clinical)
|
 | Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma (PDF) - Apr 2018 (experimental)
|
 | Physical exercise and glaucoma: a review on the roles of physical exercise on intraocular pressure control, ocular blood flow regulation, neuroprotection and glaucoma-related mental health (PDF) - Mar 2018 (clinical)
|
 | Analysis combining correlated glaucoma traits identifies five new risk loci for open-angle glaucoma (PDF) - Mar 2018 (experimental)
|
 | The Iridocorneal Endothelial Syndrome (PDF) - Feb 2018 (clinical)
|
 | Anesthetic Preconditioning as Endogenous Neuroprotection in Glaucoma (PDF) - Feb 2018 (experimental)
|
 | Detecting Visual Field Progression (PDF) - Jan 2018 (clinical)
|
 | ASK1 in neurodegeneration (PDF) - Jan 2018 (experimental)
|
 | Multiple Temporal Lamina Cribrosa Defects in Myopic Eyes with Glaucoma and Their Association with Visual Field Defects (PDF) - Dec 2017 (clinical)
|
 | Peptides of the variable IgG domain as potential biomarker candidates in primary open-angle glaucoma (POAG) (PDF) - Dec 2017 (experimental)
|
 | Rates of Local Retinal Nerve Fiber Layer Thinning before and after Disc Hemorrhage in Glaucoma (PDF) - Nov 2017 (clinical)
|
 | Retinal Astrocytes and GABAergic Wide-Field Amacrine Cells Express PDGFRα: Connection to Retinal Ganglion Cell Neuroprotection by PDGF-AA (PDF) - Nov 2017 (experimental)
|
 | Genetic correlations between intraocular pressure, blood pressure and primary open-angle glaucoma: a multi-cohort analysis (PDF) - Oct 2017 (clinical)
|
 | Successful optic nerve regeneration in the senescent zebrafish despite age-related decline of cell intrinsic and extrinsic response processes (PDF) - Oct 2017 (experimental)
|
 | Rates of glaucomatous visual field change after trabeculectomy (PDF) - Sep 2017 (clinical)
|
 | Mitochondrial dysfunction in ocular disease: Focus on glaucoma (PDF) - Sep 2017 (experimental)
|
 | Risk Factors for Rapid Glaucoma Disease Progression (PDF) - Jul 2017 (clinical)
|
 | Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss (PDF) - Jul 2017 (experimental)
|
 | Mitochondrial dysfunction in ocular disease: Focus on glaucoma (PDF) - Jun 2017 (clinical)
|
 | Regulation of intraocular pressure by microRNA cluster miR-143/145 (PDF) - Jun 2017 (experimental)
|
 | Neuroprotection for glaucoma: Requirements for clinical translation (PDF) - May 2017 (clinical)
|
 | Restoration of Aqueous Humor Outflow Following Transplantation of iPSC-Derived Trabecular Meshwork Cells in a Transgenic Mouse Model of Glaucoma (PDF) - May 2017 (experimental)
|
 | The challenge of regenerative therapies for the optic nerve in glaucoma (PDF) - Mar 2017 (clinical)
|
 | The pressure-induced deformation response of the human lamina cribrosa: Analysis of regional variations (PDF) - Mar 2017 (experimental)
|
 | Posner-Schlossman Syndrome (PDF) - Feb 2017 (clinical)
|
 | New insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristics (PDF) - Feb 2017 (experimental)
|
 | Glaucoma Risk Alleles in the Ocular Hypertension Treatment Study (PDF) - Jan 2017 (clinical)
|
 | Lamina cribrosa in glaucoma (PDF) - Jan 2017 (experimental)
|
 | New classes of glaucoma medications (PDF) - Dec 2016 (clinical)
|
 | The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection (PDF) - Dec 2016 (experimental)
|
 | Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial (PDF) - Nov 2016 (clinical)
|
 | Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine (PDF) - Nov 2016 (experimental)
|
 | Monitoring ocular hypertension, how much and how often? A cost-effectiveness perspective (PDF) - Oct 2016 (clinical)
|
 | Assessing the Association of Mitochondrial Genetic Variation With Primary Open-Angle Glaucoma Using Gene-Set Analyses (PDF) - Oct 2016 (experimental)
|
 | The Relative Odds of Progressing by Structural and Functional Tests in Glaucoma (PDF) - Sep 2016 (clinical)
|
 | Glaucoma related Proteomic Alterations in Human Retina Samples (PDF) - Sep 2016 (experimental)
|
 | Importance of Normal Aging in Estimating the Rate of Glaucomatous Neuroretinal Rim and Retinal Nerve Fiber Layer Loss (PDF) - Jul 2016 (clinical)
|
 | Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity (PDF) - Jul 2016 (experimental)
|
 | Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up (PDF) - Jun 2016 (clinical)
|
 | Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma (PDF) - Jun 2016 (experimental)
|
 | Diabetes, Triglyceride Levels, and Other Risk Factors for Glaucoma in the National Health and Nutrition Examination Survey 2005-2008 (PDF) - May 2016 (clinical)
|
 | The Potential of Human Stem Cells for the Study and Treatment of Glaucoma (PDF) - May 2016 (experimental)
|
 | The Pathogenesis of Raised Intraocular Pressure in Uveitis (PDF) - Apr 2016 (clinical)
|
 | Transplanted neurons integrate into adult retinas and respond to light (PDF) - Apr 2016 (experimental)
|
 | Rate and Pattern of Rim Area Loss in Healthy and Progressing Glaucoma Eyes (PDF) - Mar 2016 (clinical)
|
 | Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model (PDF) - Mar 2016 (experimental)
|
 | Microstructure of Peripapillary Atrophy and Subsequent Visual Field Progression in Treated Primary Open-Angle Glaucoma (PDF) - Jan 2016 (clinical)
|
 | Decreased Energy Capacity and Increased Autophagic Activity in Optic Nerve Axons With Defective Anterograde Transport (PDF) - Jan 2016 (experimental)
|
 | Trabeculectomy Can Improve Long-Term Visual Function in Glaucoma (PDF) - Dec 2015 (clinical)
|
 | Measurement of Systemic Mitochondrial Function in Advanced Primary Open-Angle Glaucoma and Leber Hereditary Optic Neuropathy (PDF) - Dec 2015 (experimental)
|
 | Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up (PDF) - Nov 2015 (clinical)
|
 | Intraocular pressure reduction and neuroprotection conferred by bone marrow-derived mesenchymal stem cells in an animal model of glaucoma (PDF) - Nov 2015 (experimental)
|
 | Association between Platelet Function and Disc Hemorrhage in Patients with Normal Tension Glaucoma: A prospective cross-sectional study (PDF) - Oct 2015 (clinical)
|
 | Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation (PDF) - Oct 2015 (experimental)
|
 | Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up (PDF) - Sep 2015 (clinical)
|
 | In vivo imaging of axonal transport of mitochondria in the diseased and aged mammalian CNS (PDF) - Sep 2015 (experimental)
|
 | Relationship Between Daytime Variability of Blood Pressure or Ocular Perfusion Pressure and Glaucomatous Visual Field Progression (PDF) - Jul 2015 (clinical)
|
 | Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat (PDF) - Jul 2015 (experimental)
|
 | Structure-Function Relationship Between Bruch's Membrane Opening-Based Optic Nerve Head Parameters and Visual Field Defects in Glaucoma (PDF) - Jun 2015 (clinical)
|
 | In vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma (PDF) - Jun 2015 (experimental)
|
 | Primary congenital glaucoma outcomes: lessons from 23 years of follow-up (PDF) - May 2015 (clinical)
|
 | GluA2 Trafficking Is Involved in Apoptosis of Retinal Ganglion Cells Induced by Activation of EphB/EphrinB Reverse Signaling in a Rat Chronic Ocular Hypertension Model (PDF) - May 2015 (experimental)
|
 | Lamina cribrosa depth in different stages of glaucoma (PDF) - Apr 2015 (clinical)
|
 | A common variant mapping to CACNA1A is associated with susceptibility to exfoliation syndrome (PDF) - Apr 2015 (experimental)
|
 | Facts and myths of cerebrospinal fluid pressure for the physiology of the eye (PDF) - Mar 2015 (clinical)
|
 | Characteristic patterns of dendritic remodeling in early-stage glaucoma: evidence from genetically identified retinal ganglion cell types (PDF) - Mar 2015 (experimental)
|
 | Long-Term Follow-up in Preperimetric Open-Angle Glaucoma: Progression Rates and Associated Factors (PDF) - Feb 2015 (clinical)
|
 | Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma (PDF) - Feb 2015 (experimental)
|
 | The impact of lack of government insured routine eye examinations on the incidence of self-reported glaucoma, cataracts and vision loss (PDF) - Jan 2015 (clinical)
|
 | Cumulative mtDNA damage and mutations contribute to the progressive loss of RGCs in a rat model of glaucoma (PDF) - Jan 2015 (experimental)
|
 | Clinical outcomes in cytomegalovirus-positive posner-schlossman syndrome patients treated with topical ganciclovir therapy (PDF) - Dec 2014 (clinical)
|
 | Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo (PDF) - Dec 2014 (experimental)
|
 | Nocturnal systemic hypotension increases the risk of glaucoma progression (PDF) - Nov 2014 (clinical)
|
 | Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process (PDF) - Nov 2014 (experimental)
|
 | Optic Nerve Head Deformation in Glaucoma: The Temporal Relationship between Optic Nerve Head Surface Depression and Retinal Nerve Fiber Layer Thinning (PDF) - Oct 2014 (clinical)
|
 | Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma (PDF) - Oct 2014 (experimental)
|
 | Rates of retinal nerve fiber layer thinning in glaucoma suspect eyes (PDF) - Sep 2014 (clinical)
|
 | Artemin augments survival and axon regeneration in axotomized retinal ganglion cells (PDF) - Sep 2014 (experimental)
|
 | The effect of positional changes on intraocular pressure during sleep in patients with and without glaucoma (PDF) - Jul 2014 (clinical)
|
 | Optic Nerve Head Blood Flow Response to Reduced Ocular Perfusion Pressure by Alteration of Either the Blood Pressure or Intraocular Pressure (PDF) - Jul 2014 (experimental)
|
 | Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study (PDF) - Jun 2014 (clinical)
|
 | Discovery and Functional Annotation of SIX6 Variants in Primary Open-Angle Glaucoma (PDF) - Jun 2014 (experimental)
|
 | Effect of Focal Lamina Cribrosa Defect on Glaucomatous Visual Field Progression (PDF) - May 2014 (clinical)
|
 | MMPs in the neuroretina and optic nerve: modulators of glaucoma pathogenesis and repair? (PDF) - May 2014 (experimental)
|
 | Intraocular pressure fluctuation and glaucoma progression: what do we know? (PDF) - Apr 2014 (clinical)
|
 | γ-Synuclein Antibodies Have Neuroprotective Potential on Neuroretinal Cells via Proteins of the Mitochondrial Apoptosis Pathway (PDF) - Apr 2014 (experimental)
|
 | The Potential Association Between Postmenopausal Hormone Use and Primary Open-Angle Glaucoma (PDF) - Mar 2014 (clinical)
|
 | Mitochondrial DNA Variant Discovery in Normal-Tension Glaucoma Patients by Next-Generation Sequencing (PDF) - Mar 2014 (experimental)
|
 | The 5-Year Incidence of Bleb-Related Infection and Its Risk Factors after Filtering Surgeries with Adjunctive Mitomycin C: Collaborative Bleb-Related Infection Incidence and Treatment Study 2 (PDF) - Feb 2014 (clinical)
|
 | Emerging novel roles of neuropeptide Y in the retina: From neuromodulation to neuroprotection (PDF) - Feb 2014 (experimental)
|
 | Relationship between Preferred Sleeping Position and Asymmetric Visual-field Loss in Open-angle Glaucoma Patients (PDF) - Jan 2014 (clinical)
|
 | Regulation of Plasticity and Fibrogenic Activity of Trabecular Meshwork Cells by Rho GTPase Signaling (PDF) - Jan 2014 (experimental)
|
 | Does optic nerve head surface topography change prior to loss of retinal nerve fiber layer thickness: a test of the site of injury hypothesis in experimental glaucoma (PDF) - Dec 2013 (clinical)
|
 | Anti-Connective Tissue Growth Factor Antibody Treatment Reduces Extracellular Matrix production in Trabecular Meshwork and Lamina Cribrosa cells (PDF) - Dec 2013 (experimental)
|
 | Pathogenesis and clinical implications of optic disk hemorrhage in glaucoma (PDF) - Nov 2013 (clinical)
|
 | Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome (PDF) - Nov 2013 (experimental)
|
 | Lifetime Risk of Blindness in Open-Angle Glaucoma (PDF) - Oct 2013 (clinical)
|
 | Immune response against ocular tissues after immunization with optic nerve antigens in a model of autoimmuneglaucoma (PDF) - Oct 2013 (experimental)
|
 | The Ahmed Versus Baerveldt Study: Three-Year Treatment Outcomes (PDF) - Sep 2013 (clinical)
|
 | Onset and Progression of Peripapillary Retinal Nerve Fiber Layer (RNFL) Retardance Changes Occur Earlier than RNFL Thickness Changes in Experimental Glaucoma (PDF) - Sep 2013 (experimental)
|
 | Rho-associated kinase inhibitors: A novel glaucoma therapy (PDF) - Jul 2013 (clinical)
|
 | Ocular Rigidity, Outflow facility, Ocular Pulse Amplitude and Pulsatile Ocular Blood Flow in Open AngleGlaucoma; a manometric study (PDF) - Jul 2013 (experimental)
|
 | Prevalence and Severity of Undetected Manifest Glaucoma: Results from the Early Manifest Glaucoma Trial Screening (PDF) - Jun 2013 (clinical)
|
 | Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma (PDF) - Jun 2013 (experimental)
|
 | The eye and the heart (PDF) - May 2013 (clinical)
|
 | Reduction in Blood Glutathione Levels Occurs Similarly in Patients with Primary-Open Angle or Normal Tension Glaucoma (PDF) - May 2013 (experimental)
|
 | How Does Glaucoma Look?: Patient Perception of Visual Field Loss (PDF) - Apr 2013 (clinical)
|
 | Tissue engineering the retinal ganglion cell nerve fiber layer (PDF) - Apr 2013 (experimental)
|
 | Treatment Outcomes in Malignant Glaucoma (PDF) - Mar 2013 (clinical)
|
 | Discovery of novel human aquaporin-1 blockers (PDF) - Mar 2013 (experimental)
|
 | Association between Myopia and Glaucoma in the United States Population (PDF) - Feb 2013 (clinical)
|
 | Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cell line (PDF) - Feb 2013 (experimental)
|
 | Balance control in glaucoma (PDF) - Jan 2013 (clinical)
|
 | A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits (PDF) - Jan 2013 (experimental)
|
 | Factors that influence standard automated perimetry test results in glaucoma: test reliability, technician experience, time of day, and season (PDF) - Dec 2012 (clinical)
|
 | Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient (PDF) - Dec 2012 (experimental)
|
 | Retinal Vessel Caliber Is Associated with the 10-year Incidence of Glaucoma: The Blue Mountains Eye Study (PDF) - Nov 2012 (clinical)
|
 | Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma (PDF) - Nov 2012 (experimental)
|
 | Longitudinal effect of topical antiglaucoma medications on central corneal thickness (PDF) - Oct 2012 (clinical)
|
 | Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma (PDF) - Oct 2012 (experimental)
|
 | Practical landmarks for visual field disability in glaucoma (PDF) - Sep 2012 (clinical)
|
 | siRNA Silencing of Gene Expression in Trabecular Meshwork: RhoA siRNA Reduces IOP in Mice (PDF) - Sep 2012 (experimental)
|
 | The Relationship Between Statin Use and Open-Angle Glaucoma (PDF) - Jul 2012 (clinical)
|
 | Structural and functional abnormalities of retinal ganglion cells measured in vivo at the onset of optic nerve head surface change in experimental glaucoma (PDF) - Jul 2012 (experimental)
|
 | Do patients with glaucoma have difficulty recognising faces? (PDF) - Jun 2012 (clinical)
|
 | IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma (PDF) - Jun 2012 (experimental)
|
 | Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma (PDF) - May 2012 (clinical)
|
 | JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death (PDF) - May 2012 (experimental)
|
 | The effect of thin, thick, and normal corneas on Goldmann intraocular pressure measurements and correction formulae in individual eyes (PDF) - Apr 2012 (clinical)
|
 | Cerebrospinal fluid exchange in the optic nerve in normal-tension glaucoma (PDF) - Apr 2012 (experimental)
|
 | Cataract surgery after trabeculectomy: the effect on trabeculectomy function (PDF) - Mar 2012 (clinical)
|
 | Multipotent Stem Cells from Trabecular Meshwork Become Phagocytic TM cells (PDF) - Mar 2012 (experimental)
|
 | Outcomes of different management options for malignant glaucoma: a retrospective study (PDF) - Feb 2012 (clinical)
|
 | A New Approach to Assess Intracranial White Matter Abnormalities in Glaucoma Patients Changes of Fractional Anisotropy Detected by 3T Diffusion Tensor Imaging (PDF) - Feb 2012 (experimental)
|
 | Optic nerve sheath diameter in normal-tension glaucoma patients (PDF) - Jan 2012 (clinical)
|
 | Vision deficits precede structural losses in a mouse model of mitochondrial dysfunction and progressive retinal degeneration (PDF) - Jan 2012 (experimental)
|
 | The Association between Glaucomatous and Other Causes of Optic Neuropathy and Sleep Apnea. (PDF) - Dec 2011 (clinical)
|
 | IOP-Induced Lamina Cribrosa Deformation and Scleral Canal Expansion: Independent or Related? (PDF) - Dec 2011 (experimental)
|
 | Shrinkage of the scleral canal during cupping reversal in children. (PDF) - Nov 2011 (clinical)
|
 | Identification of a Novel Locus for Autosomal Dominant Primary Open Angle Glaucoma on 4q35.1-q35.2. (PDF) - Nov 2011 (experimental)
|
 | Intraocular Pressure Control and Long-term Visual Field Loss in the Collaborative Initial Glaucoma Treatment Study (PDF) - Oct 2011 (clinical)
|
 | 24-Hour IOP Telemetry in the Non-human Primate: Implant System Performance and Initial Characterization of IOP At Multiple Timescales (PDF) - Oct 2011 (experimental)
|
 | Vision loss and recovery after trabeculectomy: risk and associated risk factors (PDF) - Sep 2011 (clinical)
|
 | Activated retinal glia mediated axon regeneration in experimental glaucoma (PDF) - Sep 2011 (experimental)
|
 | Trans-lamina cribrosa pressure difference correlated with neuroretinal rim area in glaucoma (PDF) - Aug 2011 (clinical)
|
 | During Glaucoma, {alpha}2-Macroglobulin Accumulates in Aqueous Humor and Binds to Nerve Growth Factor, Neutralizing Neuroprotection (PDF) - Aug 2011 (experimental)
|
 | Lifestyle and risk of developing open-angle glaucoma: the Rotterdam study (PDF) - Jul 2011 (clinical)
|
 | Ex vivo optical coherence tomography imaging of collector channels with a scanning endoscopic probe (PDF) - Jul 2011 (experimental)
|
 | Risk factors for visual field progression in treated glaucoma (PDF) - Jun 2011 (clinical)
|
 | Distortion of axonal cytoskeleton: an early sign of glaucomatous damage (PDF) - Jun 2011 (experimental)
|
 | The Relationship Between Components of Metabolic Syndrome and Open-Angle Glaucoma (PDF) - May 2011 (clinical)
|
 | Elastic modulus determination of normal and glaucomatous human trabecular meshwork (PDF) - May 2011 (experimental)
|
 | A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study (PDF) - Apr 2011 (clinical)
|
 | Early Gene Expression Changes in the Retinal Ganglion Cell Layer of a Rat Glaucoma Model (PDF) - Apr 2011 (experimental)
|
 | Investigation of the Association between Helicobacter pylori Infection and Normal Tension Glaucoma (PDF) - Mar 2011 (clinical)
|
 | Imaging the aqueous humor outflow pathway in human eyes by three-dimensional micro-computed tomography (3D micro-CT) (PDF) - Mar 2011 (experimental)
|
 | Laminar and prelaminar tissue displacement during intraocular pressure elevation in glaucoma patients and healthy controls (PDF) - Feb 2011 (clinical)
|
 | Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma (PDF) - Feb 2011 (experimental)
|
 | Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection (PDF) - Jan 2011 (clinical)
|
 | Reversal of retinal ganglion cell dysfunction after surgical reduction of intraocular pressure (PDF) - Jan 2011 (experimental)
|
 | Predicting visual function from the measurements of retinal nerve fiber layer structure (PDF) - Dec 2010 (clinical)
|
 | Genetic architecture of open angle glaucoma and related determinants (PDF) - Dec 2010 (experimental)
|
 | Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change (PDF) - Nov 2010 (clinical)
|
 | Qualitative and quantitative morphologic changes in the vasculature and extracellular matrix of the prelaminar optic nerve head in eyes with POAG (PDF) - Nov 2010 (experimental)
|
 | Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study (PDF) - Oct 2010 (clinical)
|
 | Functional MRI signal changes in primary visual cortex corresponding to the central normal visual field of patients with primary open-angle glaucoma (PDF) - Oct 2010 (experimental)
|
 | Anthropometric measures and their relation to incident primary open-angle glaucoma (PDF) - Sep 2010 (clinical)
|
 | Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve (PDF) - Sep 2010 (experimental)
|
 | Effect of sleeping in a head-up position on intraocular pressure in patients with glaucoma (PDF) - Aug 2010 (clinical)
|
 | Genome-wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility (PDF) - Aug 2010 (experimental)
|
 | Clinical classification of childhood glaucomas (PDF) - Jul 2010 (clinical)
|
 | Mitochondrial damage in the trabecular meshwork of patients with glaucoma (PDF) - Jul 2010 (experimental)
|
 | Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension (PDF) - Jun 2010 (clinical)
|
 | Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration (PDF) - Jun 2010 (experimental)
|
 | Delaying Treatment of Ocular Hypertension: the Ocular Hypertension Treatment Study (PDF) - May 2010 (clinical)
|
 | Neuroprotective Effects of Intravitreal Mesenchymal Stem Cell Transplantation in Experimental Glaucoma (PDF) - May 2010 (experimental)
|
 | Simvastatin and Disease Stabilization in Normal Tension Glaucoma: A Cohort Study. (PDF) - Mar 2010 (clinical)
|
 | Episcleral Venous Pressure Responses to Topical Nitroprusside and N-Nitro-L-arginine Methyl Ester. (PDF) - Mar 2010 (experimental)
|
 | Cerebrospinal Fluid Pressure in Glaucoma A Prospective Study. (PDF) - Feb 2010 (clinical)
|
 | Hemoglobin expression and regulation in glaucoma: insights into retinal ganglion cell oxygenation. (PDF) - Feb 2010 (experimental)
|
 | Prediction of glaucomatous visual field loss by extrapolation of linear trends (PDF) - Jan 2010 (clinical)
|
 | Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration (PDF) - Jan 2010 (experimental)
|
 | Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki Eye Study (PDF) - Nov 2009 (clinical)
|
 | Complex antibody profile changes in an experimental autoimmune glaucoma animal model (PDF) - Oct 2009 (clinical)
|